Stop the war!

Остановите войну!

for scientists:

default search action

combined dblp search
author search
venue search
publication search

ask others

Jeroen van der Laak

Name: dblp XML data dump
Creator: Schloss Dagstuhl - Leibniz Center for Informatics
Published: 1993
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: dblp, XML, computer science, scholarly publications, metadata

◀ ▶ joint publications with Filippo Fraggetta

> Home > Persons > Jeroen van der Laak

Publications

2022
[j16]
- view
  authority control:
- export record
  dblp key:
  - journals/npjdm/Marini0OWCRABPP22
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/npjdm/Marini0OWCRABPP22
Niccolò Marini, Stefano Marchesin, Sebastian Otálora, Marek Wodzinski, Alessandro Caputo, Mart van Rijthoven, Witali Aswolinskiy, John-Melle Bokhorst, Damian Podareanu, Edyta Petters, Svetla Boytcheva, Genziana Buttafuoco, Simona Vatrano, Filippo Fraggetta, Jeroen van der Laak, Maristella Agosti, Francesco Ciompi, Gianmaria Silvello, Henning Müller, Manfredo Atzori:
Unleashing the potential of digital pathology data by training computer-aided diagnosis models without human annotations. npj Digit. Medicine 5 (2022)
2021
[i16]
- view
  - electronic edition @ arxiv.org (open access)
  - references & citations
- export record
  dblp key:
  - journals/corr/abs-2109-07892
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/corr/abs-2109-07892
John-Melle Bokhorst, Iris D. Nagtegaal, Filippo Fraggetta, Simona Vatrano, Wilma Mesker, Michael Vieth, Jeroen van der Laak, Francesco Ciompi:
Automated risk classification of colon biopsies based on semantic segmentation of histopathology images. CoRR abs/2109.07892 (2021)

a service of

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.